| Date | Time | Source | Headline | Symbol | Company |
| 06/17/2011 | 2:30AM | Business Wire | Data Suggests Treatment with FOLOTYN® Reverses Trend of Progressive Resistance Observed in Patients with Drug-Resistant Rela... | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 06/16/2011 | 2:30AM | Business Wire | COMPLETE Registry Provides First Glance into Treatment Patterns for Patients with Peripheral T-Cell Lymphoma | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 06/08/2011 | 9:00AM | Business Wire | FOLOTYN® Data to be Presented at the Congress of the European Hematology Association & the International Conference on Malig... | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 06/06/2011 | 3:57PM | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 05/20/2011 | 12:49PM | Zacks | Risk-Reward Balanced at Allos - Analyst Blog | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 05/16/2011 | 4:14PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 05/13/2011 | 12:55PM | Zacks | 1Q Loss Narrows at Allos - Analyst Blog | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 05/10/2011 | 5:24PM | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 05/10/2011 | 4:11PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 05/10/2011 | 4:05PM | Business Wire | Allos Therapeutics and Mundipharma Announce Strategic Collaboration for FOLOTYN | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 05/10/2011 | 4:00PM | Business Wire | Allos Therapeutics Reports First Quarter 2011 Financial Results | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 05/06/2011 | 2:42PM | Zacks | Mixed Results for CELG's Revlimid - Analyst Blog | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 05/04/2011 | 8:00AM | Business Wire | Allos Therapeutics to Present at Upcoming Investor Conferences in May | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 05/03/2011 | 8:00AM | Business Wire | Allos Therapeutics to Report First Quarter 2011 Results on May 10, 2011 | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 05/02/2011 | 8:16AM | Marketwired | Oncology Drug Makers Positioned for Long Term Growth | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 04/29/2011 | 4:48PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 04/29/2011 | 12:35PM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 04/29/2011 | 12:31PM | Edgar (US Regulatory) | Proxy Statement (definitive) (DEF 14A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 04/05/2011 | 1:01PM | Zacks | Allos Therapeutics at Neutral - Analyst Blog | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 04/04/2011 | 11:20AM | Zacks | Cancer Study to Continue at SPPI - Analyst Blog | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 03/30/2011 | 8:00AM | Business Wire | Allos Therapeutics to Present at Upcoming Investor Conferences | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 03/18/2011 | 4:26PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 03/17/2011 | 7:35AM | Marketwired | Speculative Biotech Firms Remain Popular Takeover Targets | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 03/04/2011 | 4:27PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 03/03/2011 | 4:20PM | Edgar (US Regulatory) | Annual Report (10-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 03/03/2011 | 4:15PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 03/03/2011 | 4:00PM | Business Wire | Allos Therapeutics Announces Special Protocol Assessment Agreement with FDA for Phase 3 Trial of FOLOTYN in Patients with Pre... | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 03/03/2011 | 4:00PM | Business Wire | Allos Therapeutics Reports Fourth Quarter and Full Year 2010 Financial Results | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 03/02/2011 | 5:10PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 03/02/2011 | 5:09PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |